Search

Tetragenetics Anti-Kv1.3 Antibody Patent EP3452084A1

The European Patent Office published patent application EP3452084A1 for Tetragenetics, Inc., titled 'ANTI-KV1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF,' with a publication date of April 15, 2026. The patent covers anti-Kv1.3 antibodies and their production and use, classified under A61P 37/06 for autoimmune and inflammatory disease applications. Designated states include all 31 EPC contracting states across the European Union and beyond.